Log in

Neoadjuvant Chemotherapy: Does It Have Benefits for the Surgeon in the Treatment of Advanced Squamous Cell Cancer of the Oral Cavity?

  • Published:
Pathology & Oncology Research

Abstract

The purpose of this clinicopathological study was to evaluate the effects and efficiency of combined neoadjuvant chemotherapy related to surgical margin. 100 consecutively treated squamous cell cancer patients receiving a combined neoadjuvant therapy were selected (Bleomycin—Vincristin—Methotrexate (BVM) or BVM + Mitolactol or BVM + Cisplatin). After three courses of chemotherapy, the patients were operated on. The largest diameter of the primary tumors was compared before and after chemotherapy. In the surgical specimen, the involvement of surgical margin was assessed. The largest diameter before chemotherapy was: T2 30%; T3 55%; T4A 15%. After chemotherapy, the rest tumor was assessed in the surgical specimen as: no rest 11%; <2 cm 57%; 2–4 cm 28%; 4–6 cm 4%. The no rest and <2 cm (optimal operability) tumor was observed in T2: 94%; in T3: 73%; in the T4A: 0%. Severe side effects (Grade III–IV) were not observed. There was a significant decrease in size (P < 0.0001). Of the 100 surgical specimens, 83% had clear-, 9% close- and 8% involved margins. From T4A, there was a 40% (6 patients) involved margin. Based on the significantly better size and operability of primary T2-3, the mild side effects and the high (83%) percentage of clear surgical margins, that is better than other (without preoperative chemotherapy) results, sought the use of chemotherapy is recommended before surgery. Due to the 40% involved margin, we don’t suggest surgery in T4A.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gaudi I, Kásler M (2002) The course of cancer mortality in Hungary between 1975–2001 (English abstract). Magy Onkol 46:291–295

    PubMed  Google Scholar 

  2. Zs N, Velich N, Bogdán S et al (2005) The prognostic role of clinical, morphological and molecular markers in oral squamosus cell tumors. Neoplasma 52:95–101

    Google Scholar 

  3. Taylor SG (1997) Head and neck cancer. Cancer Chemot Biol Response Mod Ann 17 Elsev Science

  4. Gibson MK, Forastiere AA (2004) Multidisciplinary approaches in the management of advanced head and neck tumors: state of art. Curr Opin Oncol 16:220–224

    Article  PubMed  Google Scholar 

  5. Forastiere AA (2004) Is there a new role for induction chemotherapy in the treatment of head and neck cancer? J Natl Cancer Inst 96:1647–1649

    CAS  PubMed  Google Scholar 

  6. Gibson MK, Forestiere AA (2006) Reassassment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol 7:565–574

    Article  PubMed  Google Scholar 

  7. Bryne M, Koppang HS, Lilleng R et al (1992) Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166:375–381

    Article  CAS  PubMed  Google Scholar 

  8. Spiro RH, Guillamondegui O, Paulin AF et al (1999) Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 21:408–413

    Article  CAS  PubMed  Google Scholar 

  9. Cooper JS, Pajak TF, Forastiere AA et al (2004) Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944

    Article  PubMed  Google Scholar 

  10. Loree TR, Strong EW (1990) Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 160:410–414

    Article  CAS  PubMed  Google Scholar 

  11. Sutton DN, Brown JS, Rogers SN et al (2003) The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32:30–34

    Article  CAS  PubMed  Google Scholar 

  12. Beitler JJ, Smith RV, Silver CE et al (1998) Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radial Oncol Biol Phys 40:313–317

    CAS  Google Scholar 

  13. Jacobs JR, Ahmad K, Casiano R et al (1993) Implications of positive surgical margins. Laryngoscope 103:64–68

    Article  CAS  PubMed  Google Scholar 

  14. Batsakis JG (1999) Surgical excision margins: a pathologist’s perspective. Adv Anat Pathol 6:140–148

    Article  CAS  PubMed  Google Scholar 

  15. Woolgar JA, Rogers S, West CR et al (1999) Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 35:257–265

    Article  CAS  PubMed  Google Scholar 

  16. Licitra L, Grandi C, Guzzo M et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327–333

    Article  CAS  PubMed  Google Scholar 

  17. Bettendorf O, Piffko J, Bankfalvi A (2004) Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol 40:110–119

    Article  CAS  PubMed  Google Scholar 

  18. Beckmann GK, Hoppe F, Pfreundner L et al (2005) Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck 27:36–43

    Article  PubMed  Google Scholar 

  19. van Es RJJ, van Nieuw-Amerongen N, Slootweg PJ et al (1996) Resection margin as a predictor or recurrence at the primary site for T1 and T2 oral cancers. Arch Otolaryngol Head Neck Surg 122:521–525

    PubMed  Google Scholar 

  20. Perez CA, Marks J, Powers W (1977) Preoperative irradiation in head and neck cancer. Semin Oncol 4:387–397

    CAS  PubMed  Google Scholar 

  21. Stevens KR, Moss WT (1975) Control of localised cancer. Combination of preoperative irradiation and surgery. JAMA 232:1158–1160

    Article  PubMed  Google Scholar 

  22. Carifi VG, Ohanion ML et al (1974) Results of high dose radiation and surgery in the treatment of advanced cancer of the head and neck. Am J Surg 128:580–582

    Article  CAS  PubMed  Google Scholar 

  23. Mohr C, Bohndorf W, Carstens J et al (1994) Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective multicentric randomised DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow up). Int J Oral Maxillofac Surg 23:140–148

    Article  CAS  PubMed  Google Scholar 

  24. Volling P, Schroder M, Muller RP et al (1994) Induction chemotherapy in primary resectable head and neck tumors: a prospective randomized trial. Int J Oncol 4:909–914

    Google Scholar 

  25. Jakobs C, Makuch R (1999) Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the head and neck contracts program. J Clin Oncol 8:838–847

    Google Scholar 

  26. Maipang T, Maipang M, Geater A et al (1995) Combination chemotherapy as induction therapy for advanced resectable head and neck cancer. J Surg Oncol 59:80–85

    Article  CAS  PubMed  Google Scholar 

  27. Olasz L, Kwashie F, Herczegh P et al (1996) A comparative study of preoperative B-V-M-M chemotherapy and irradiation in advanced squamous cell cancer of the oral cavity. Neoplasma 43:51–56

    CAS  PubMed  Google Scholar 

  28. Kovacs AF, Turowski B, Ghahremani MT et al (1999) Intraarterial chemotherapy as neoadjuvant treatment of oral cancer. J Craniomaxillofac Surg 27:302–307

    CAS  PubMed  Google Scholar 

  29. AlSarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284

    CAS  Google Scholar 

  30. Benasso M, Lionetto R, Corvo R et al (2003) Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation. Eur J Cancer 39:1895–1898

    Article  CAS  PubMed  Google Scholar 

  31. Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomised comparison between definitive chemoradiotherapy and radical surgery in patients with T 2–3 Nany Mo squamous cell carcinoma of the esophagus. Int J Rad Oncol Biol Phys 57:425–433

    Article  Google Scholar 

  32. Psyrri A, Kwong M, DiStasio S et al (2004) Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol 22:3061–3069

    Article  CAS  PubMed  Google Scholar 

  33. Forastiere AA, Trotti A (1999) Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional contro and survival in oropharyngeal cancer. J Natl Cancer Inst 91:2056–2066

    Article  Google Scholar 

  34. Basu S, Khanra M, Dash B et al (1999) The role of neoadjuvant and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer. Med Oncol 16:199–203

    Article  CAS  PubMed  Google Scholar 

  35. Olasz L, Szabó I, Horvath A (1988) A combined treatment for advanced oral cavity cancers. Cancer 62:1267–1274

    Article  CAS  PubMed  Google Scholar 

  36. Price LA, Hill BT (1986) Impact of primary site Stage III and IV squamous cell carcinomas of the head and neck on 7-year survival figures following initial noncisplatin-containing combination chemotherapy. Resent Results Cancer Res 103:124–134

    CAS  Google Scholar 

  37. Athanasiadis J, Taylor S, Vokes EE et al (1997) Phase II. study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Rec Res Cancer 79:588–594

    CAS  Google Scholar 

  38. Grégoire V, Beauduin M, Humblet Y et al (1991) A phase I–II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: report from the UCL-Oncology Group, Belgium. J Clin Oncol 9:1385–1392

    PubMed  Google Scholar 

  39. Gibson MK, Li Y, Murphy B et al (2005) Eastern Cooperative Oncology Group. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23:3562–3567

    Article  CAS  PubMed  Google Scholar 

  40. Braun OM, Neumeister B, Neuhold N et al (1989) Histological grading of therapy induced regression in squamous cell carcinomas of the oral cavity. A morphological and immunohistochemical study. Path Res Pract 185:368–372

    CAS  PubMed  Google Scholar 

  41. Sulfaro S, Frustaci S, Volpe R et al (1989) A pathologic assessment of residue and stromal changes after intra-arterial chemotherapy for head and neck carcinomas. Cancer 64:994–1001

    Article  CAS  PubMed  Google Scholar 

  42. Suba Z, Szabó G, Barabás J et al (1992) Histological evaluation of chemotherapeutically induced regression. Reg Cancer Treat 4:313–319

    Google Scholar 

  43. Olasz L, Németh Á, Nyárády Z et al (2004) Results and failures with or without cisplatin containing induction chemotherapy in the treatment of squamous cell carcinoma of the head and neck. Cancer Det Prev 28:65–71

    Article  CAS  Google Scholar 

  44. Giralt JL, Gonzalez J, del Campo JM et al (2000) Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 89:939–945

    Article  CAS  PubMed  Google Scholar 

  45. Posner MR, Glisson B, Frenette G et al (2001) Multicenter phase I–II trial of docetaxel, cisplatin and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol 19:1096–1104

    CAS  PubMed  Google Scholar 

  46. Woolgar JA, Rogers SN, Lowe D et al (2003) Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol 39:130–137

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest and funding source

All authors state that there are no financial interests or commercial associations that may create a conflict of interest with information presented in this manuscript.

There is no involvement of any study sponsors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lajos Olasz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olasz, L., Szalma, J., Orsi, E. et al. Neoadjuvant Chemotherapy: Does It Have Benefits for the Surgeon in the Treatment of Advanced Squamous Cell Cancer of the Oral Cavity?. Pathol. Oncol. Res. 16, 207–212 (2010). https://doi.org/10.1007/s12253-009-9208-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-009-9208-3

Keywords

Navigation